Rhea Co-amoxiclav

Rhea Co-amoxiclav Description

amoxicillin + clavulanic acid

Manufacturer:

GlaxoSmithKline

Distributor:

Philusa
Full Prescribing Info
Description
Tablets: Co-amoxiclav 625 mg Tablet: Each tablet contains 500 mg amoxicillin and 125 mg clavulanic acid.
Co-amoxiclav (beta-lactam antibacterial penicillin coformulated with a beta-lactamase inhibitor) is an antibiotic agent with a notably broad spectrum of activity against the commonly occurring bacterial pathogens in general practice and hospital. The beta-lactamase inhibitory action of clavulanate extends the spectrum of amoxicillin to embrace a wider range of organisms, including many resistant to other beta-lactam antibiotics.
Powder for Suspension (in bottles): Co-amoxiclav 312.5 mg/5mL Powder for Suspension: Bottles of powder for the preparation of fruit flavoured suspension. When reconstituted, each 5mL contains 250 mg amoxicillin and 62.5 mg clavulanic acid.
Co-amoxiclav 457 mg/5mL Powder for Suspension: Bottles of powder for the preparation of strawberry flavoured suspension. When reconstituted, each 5mL contains 400mg amoxicillin and 57 mg clavulanic acid.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in